Abstract
PURPOSE: To assess the accuracy of drug self-reporting in oocyte donors. METHODS: Retrospective chart review of donors at Stanford University. RESULTS: 7% of the donor population had a significant positive urine toxicology screen. CONCLUSIONS: Donors may not fully disclose details of drug use, so urine toxicology screening should be considered in this patient population.